戻る Agenda
Session 2-1 RA track (Parallel Session) Accelerating Access Through Regulatory Innovation and Convergence
Session Chair(s)
Helene Sou, MSc, RAC
Global Regulatory Policy and Innovation, Takeda Pharmaceutical Company Limited., Singapore
Edana Loke
Assoc Dir - Asia, Australia, Africa, Middle East, Area & Affiliate Strategy, AbbVie Pte Ltd, Singapore
Speaker(s)
Yu-Hsin Hsieh
Reviewer, Division of Medicinal Products, Taiwan Food and Drug Administration, Taiwan
Evangelos Kotzagiorgis, MPharm, MS
Pharmaceutical Quality Senior Specialist, Pharmaceutical Quality Office, Human M, EMA, Netherlands
Suat Gnoh Por
Senior Regulatory Program Director, Roche Singapore Technical Operations Pte Ltd, Singapore
Brix Bayuga
Director - GRA CMCD, Eli Lilly and Company, Singapore
Kai Yin Po
Principle Scientist. Regulatory Affairs, MSD Singapore, Singapore
Cameron Kieffer, PhD
Director, Global Regulatory Intelligence and Policy Research, Takeda, United States
Kyunghun Son, PhD
Director, Drug Research Div, Pharmaceutical and Medical Device Research Dept., NIFDS, MFDS, Korea, Republic of